Advancing the impact of molecular testing and diagnostics
We’re on a mission to use our open, accessible, and actionable molecular detection platform to detect pathogens before they spread.
The Alveo platform brings molecular detection out of the lab and into the field.
Access to actionable, early detection is key to managing global health, food security, and supply chain resiliency.
Three out of four new or emerging infectious diseases in people come from animals1.
Rapid detection leads to earlier insight into pathogen spread and supports efforts to secure global health and prevent future pandemics.
There have been over a thousand recorded Avian Flu outbreaks since 2016. And for every million birds lost, there is also a 1.6% price increase2.
There have been over a thousand recorded Avian Flu outbreaks since 2016. And for every million birds lost, there is also a 1.6% price increase.
By 2050, we will need to feed a global population of 10 billion people3.
Global austerity, rising prices for energy, fuel, fertilizers, military conflicts, and geo-political instability in major grain/food exporting countries have compounded, creating greater instability and unpredictability in global food systems.
Currently, we lose up to a third of food crops to pathogens4.
Currently, we lose up to a third of food crops to pathogens.
Get to know the Alveo Platform
Harnessing the power of molecular detection in our handheld analyzer, Alveo enables rapid, actionable pathogen detection in a growing number of fields precisely when — and where — it matters most.
CE Marked for use in the in vitro diagnostic (IVD) molecular testing market
ISO certified for the design, development, and manufacture of in vitro diagnostic kits and analyzers for the detection of infectious disease
Winner: XPRIZE Grand Prize for Rapid Covid testing
